Safety and Efficacy Study of PB127 Ultrasound Contrast Agent for Diagnosis of Coronary Artery Disease

NCT00584896 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

1000

Enrollment

INDUSTRY

Sponsor class

Stopped Discontinued PB127 development program for business reasons

Conditions

Coronary Artery Disease

Interventions

DRUG: PB127 for Injectable Suspension

Sponsor

Point Biomedical